Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request

An Examination of US COVID-19 Vaccine Distribution in New Jersey, Pennsylvania, and New York.

Item request has been placed! ×
Item request cannot be made. ×
loading   Processing Request
  • المؤلفون: Moss E;Moss E; Patterson NA; Patterson NA; Seals BF; Seals BF
  • المصدر:
    International journal of environmental research and public health [Int J Environ Res Public Health] 2022 Nov 24; Vol. 19 (23). Date of Electronic Publication: 2022 Nov 24.
  • نوع النشر :
    Journal Article
  • اللغة:
    English
  • معلومة اضافية
    • المصدر:
      Publisher: MDPI Country of Publication: Switzerland NLM ID: 101238455 Publication Model: Electronic Cited Medium: Internet ISSN: 1660-4601 (Electronic) Linking ISSN: 16604601 NLM ISO Abbreviation: Int J Environ Res Public Health Subsets: MEDLINE
    • بيانات النشر:
      Original Publication: Basel : MDPI, c2004-
    • الموضوع:
    • نبذة مختصرة :
      COVID-19 quickly spread across the United States (US) while communications and policies at all government levels suffered from inconsistency, misinformation, and lack of coordination. In order to explain the discrepancy between availability and population uptake, a case study was conducted analyzing vaccine rollout plans, social media, and Health Officer/Other Key Informant interviews in New Jersey, New York, and Pennsylvania. Key research questions included, "What were the barriers and facilitators of early COVID vaccine distribution?" and "What mechanisms in the community emerged to alleviate strains in early vaccination?" Findings from this study revealed that pre-existing emergency preparedness infrastructures and plans developed since the 9/11 tragedy were seemingly abandoned. This caused health departments at all levels of government to make impromptu, non-uniform decisions leading to confusion, vaccine hesitancy, and ultimately low uptake. The results indicate that future vaccine rollout best practices must include evidence-based decision-making, coordinated communications, and outreach to high-priority and vulnerable communities.
    • References:
      Vaccine. 2016 Sep 22;34(41):5013-5020. (PMID: 27576074)
      Healthc Q. 2021 Apr;24(1):28-35. (PMID: 33864438)
      J Public Health Manag Pract. 2020 Mar/Apr;26(2):101-108. (PMID: 30807465)
      Vaccine. 2021 Apr 8;39(15):2024-2034. (PMID: 33722411)
      Drugs Context. 2021 Feb 16;10:. (PMID: 33643421)
      BMJ Glob Health. 2021 Sep;6(9):. (PMID: 34593513)
      Int J Equity Health. 2022 Aug 30;21(1):122. (PMID: 36042485)
      J Natl Med Assoc. 2022 Jun;114(3):265-273. (PMID: 35221074)
      Vaccines (Basel). 2022 Mar 03;10(3):. (PMID: 35335020)
      Qual Health Res. 2019 Aug;29(10):1483-1496. (PMID: 30628545)
      Front Public Health. 2021 Nov 23;9:770985. (PMID: 34888288)
      J Clin Invest. 2020 Jul 1;130(7):3348-3349. (PMID: 32352406)
      PLoS One. 2021 May 12;16(5):e0251605. (PMID: 33979412)
      Lancet. 2022 Aug 27;400(10353):e3-e7. (PMID: 35934013)
      Am J Public Health. 2021 Jun;111(6):1078-1080. (PMID: 33600253)
      MMWR Morb Mortal Wkly Rep. 2021 May 21;70(20):759-764. (PMID: 34014911)
      Curr Epidemiol Rep. 2022;9(2):66-76. (PMID: 35287290)
      Health Educ Res. 2020 Dec 23;35(6):505-511. (PMID: 33367772)
      JAMA Pediatr. 2017 Sep 1;171(9):887-892. (PMID: 28738137)
      J Clin Med. 2021 Dec 15;10(24):. (PMID: 34945172)
      Biomedicines. 2022 Mar 26;10(4):. (PMID: 35453526)
      J Clin Nurs. 2022 Jan;31(1-2):62-86. (PMID: 34227179)
      J Public Health Manag Pract. 2022 Jan-Feb 01;28(1):86-94. (PMID: 34797242)
      Vaccines (Basel). 2020 Dec 30;9(1):. (PMID: 33396832)
      JMIR Form Res. 2022 Jul 18;6(7):e33260. (PMID: 35724339)
      J Oral Pathol Med. 2021 Apr;50(4):424-427. (PMID: 33527524)
      Health Equity. 2022 Jan 17;6(1):3-12. (PMID: 35112040)
      J Law Med Ethics. 2021;49(3):495-499. (PMID: 34665094)
      J Pediatr Nurs. 2022 Jul-Aug;65:e19. (PMID: 35012869)
      BMC Public Health. 2021 Nov 13;21(1):2084. (PMID: 34774012)
      Fam Syst Health. 2020 Dec;38(4):341-345. (PMID: 33332139)
      JAMA. 2021 Mar 2;325(9):829-830. (PMID: 33512381)
      J Public Health Manag Pract. 2021 May-Jun 01;27(3):223-225. (PMID: 33762537)
      Infect Dis Now. 2021 Aug;51(5):484-487. (PMID: 33964486)
      BMC Med Res Methodol. 2011 Jun 27;11:100. (PMID: 21707982)
      JMIR Public Health Surveill. 2022 Mar 4;8(3):e33277. (PMID: 35089868)
    • Contributed Indexing:
      Keywords: pandemic; public health; vaccination; vaccine; vaccine distribution
    • الرقم المعرف:
      0 (COVID-19 Vaccines)
    • الموضوع:
      Date Created: 20221211 Date Completed: 20221216 Latest Revision: 20230120
    • الموضوع:
      20231215
    • الرقم المعرف:
      PMC9738558
    • الرقم المعرف:
      10.3390/ijerph192315629
    • الرقم المعرف:
      36497703